CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Revenue | ||||
| Total revenue, net | $ 1,225,000 | $ 2,979,000 | $ 21,497,000 | $ 5,193,000 |
| Operating expenses | ||||
| Cost of product revenue | 1,031,000 | 527,000 | 2,189,000 | 1,042,000 |
| Research and development | 3,336,000 | 3,265,000 | 7,264,000 | 6,995,000 |
| Sales and marketing | 5,000 | 2,467,000 | 901,000 | 4,960,000 |
| General and administrative | 4,450,000 | 4,727,000 | 8,558,000 | 9,624,000 |
| Total operating expenses | 8,822,000 | 10,986,000 | 18,912,000 | 22,621,000 |
| Income (loss) from operations | (7,597,000) | (8,007,000) | 2,585,000 | (17,428,000) |
| Loss on extinguishment of debt | (3,504,000) | (1,822,000) | (4,132,000) | (1,822,000) |
| Changes in fair value of freestanding and hybrid financial instruments designated at Fair Value Option | (1,918,000) | (1,068,000) | (2,255,000) | (2,411,000) |
| Interest income (expense) | (161,000) | 15,000 | (860,000) | 71,000 |
| Other income (expense) | 378,000 | 322,000 | 583,000 | 434,000 |
| Income (loss) before income tax expense | (12,802,000) | (10,560,000) | (4,079,000) | (21,156,000) |
| Income tax expense | 0 | 0 | 0 | 0 |
| Net loss before equity in net loss of joint venture | (12,802,000) | (10,560,000) | (4,079,000) | (21,156,000) |
| Equity in net loss of joint venture | 0 | 0 | 0 | |
| Net income (loss) | (12,802,000) | (10,560,000) | (4,079,000) | (21,156,000) |
| Net loss attributable to noncontrolling interest | (120,000) | (153,000) | (246,000) | (285,000) |
| Stock dividends to preferred stockholders | 0 | 0 | 9,470,000 | 0 |
| Deemed dividend to preferred stockholders | 8,000 | 0 | 6,071,000 | 0 |
| Preferred returns to preferred stockholders | 0 | 0 | 331,000 | 0 |
| Cumulative preferred dividends allocated to preferred stockholders | 11,000 | 0 | 11,000 | 0 |
| Net loss attributable to common stockholders | $ (12,701,000) | $ (10,407,000) | $ (19,716,000) | $ (20,871,000) |
| Net loss per share, basic | $ (15.7) | $ (358.94) | $ (35.11) | $ (937.26) |
| Net loss per share, diluted | $ (15.7) | $ (358.94) | $ (35.11) | $ (937.26) |
| Weighted-average common stock outstanding, basic | 809,122 | 28,994 | 561,567 | 22,268 |
| Weighted-average common stock outstanding, diluted | 809,122 | 28,994 | 561,567 | 22,268 |
| License revenue | ||||
| Revenue | ||||
| Total revenue, net | $ 43,000 | $ 43,000 | $ 19,086,000 | $ 86,000 |
| Product revenue, net | ||||
| Revenue | ||||
| Total revenue, net | 1,182,000 | $ 2,936,000 | 2,386,000 | $ 5,107,000 |
| Grant revenue | ||||
| Revenue | ||||
| Total revenue, net | $ 0 | $ 25,000 | ||
| X | ||||||||||
- Definition Equity in net loss of joint venture. No definition available.
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrants, conversion option and derivative liability. No definition available.
|
| X | ||||||||||
- Definition Net income loss before equity in net loss of joint venture. No definition available.
|
| X | ||||||||||
- Definition Preferred returns to preferred stockholders No definition available.
|
| X | ||||||||||
- Definition Stock dividends to preferred stockholders. No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|